| Title | A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Mosam, Anisa, Fahmida Shaik, Thomas S. Uldrick, Tonya Esterhuizen, Gerald H. Friedland, David T. Scadden, Jamila Aboobaker, and Hoosen M. Coovadia |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Volume | 60 |
| Issue | 2 |
| Pagination | 150-7 |
| Date Published | 2012 Jun 1 |
| ISSN | 1944-7884 |
| Keywords | Adult, Anti-HIV Agents, Antigens, Neoplasm, Antiretroviral Therapy, Highly Active, Drug Therapy, Female, Humans, Lamivudine, Male, Nevirapine, Sarcoma, Kaposi, South Africa, Stavudine, Survival Analysis, Treatment Outcome |
| Abstract | The optimal approach to HIV-associated Kaposi sarcoma (HIV-KS) in sub-Saharan Africa is unknown. With large-scale rollout of highly active antiretroviral therapy (HAART) in South Africa, we hypothesized that survival in HIV-KS would improve and administration of chemotherapy in addition to HAART would be feasible and improve KS-specific outcomes. |
| DOI | 10.1097/QAI.0b013e318251aedd |
| Alternate Journal | J. Acquir. Immune Defic. Syndr. |
